ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,867.08
-0.09%
US Tech 100
20,566.80
0.00%
Dow Jones
42,342.24
0.04%
Brent Oil
72.265
-0.17%
Bitcoin
96,037.93
-1.46%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Immupharma Plc (IMM) Quote

Immupharma Plc

Immupharma Plc (IMM)

Immutep Limited
International Metals Mining Corp
1.20
-0.08
( -6.25% )
Updated: 03:00:07
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.20
Bid
1.08
Ask
1.36
Volume
338,580
1.20 Day's Range 1.20
0.83 52 Week Range 2.90
Market Cap
4.997M
Previous Close
1.28
Open
1.20
Last Trade
100000
@
1.178
(O)
Last Trade Time
03:04:37
Financial Volume
4,063p
VWAP
1.20
Average Volume (3m)
1,385,282
Shares Outstanding
416,440,000
Dividend Yield
-
PE Ratio
-1.83
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-2.92M

About Immupharma Plc

Sector
Finance Services
Industry
Finance Diversified
Website
www.immupharma.com
Headquarters
London, Gbr
Founded
2006
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 1.28p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 2.90p.

Immupharma currently has 416,440,000 shares outstanding. The market capitalization of Immupharma is £5.33 million. Immupharma has a price to earnings ratio (PE ratio) of -1.83.

Ask ADVFN Intelligence (AI)

IMM Latest News

More News

Immupharma PLC Holding(s) in Company

Immupharma PLC 10 December 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

December 10 2024
RNS Regulatory News

Immupharma PLC Appointment of Company Secretary

Immupharma PLC 04 December 2024                                                                                                                                                                  ...

December 04 2024
RNS Regulatory News

ImmuPharma narrows losses in first half as expenses fall

ImmuPharma PLC on Monday expressed optimism about the potential of its pipeline, after narrowing pretax loss in the f ...

September 09 2024
Alliance News

ImmuPharma obtains second warrant extension with Incanthera

ImmuPharma PLC said on Monday it had extended its warrants in Incanthera PLC for the second time, valid now until Mar ...

September 09 2024
Alliance News

Immupharma PLC Extension of Warrants in Incanthera to 31 Mar 2025

Immupharma PLC 09 September 2024                                                                                                                                                                 ...

September 09 2024
RNS Regulatory News

Immupharma PLC Half-year Report

Immupharma PLC 09 September 2024   RNS: RELEASE | 9 September 2024       ImmuPharma PLC ("ImmuPharma" or the "Company")   INTERIM RESULTS for the six months ended 30 June 2024   ImmuPharma PLC...

September 09 2024
RNS Regulatory News

Immupharma PLC Holding(s) in Company

Immupharma PLC 06 August 2024   TR-1: Standard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word...

August 06 2024
RNS Regulatory News

Immupharma PLC Result of AGM

Immupharma PLC 28 June 2024       RNS: RELEASE                                                                                                                                             ...

June 28 2024
RNS Regulatory News

EARNINGS AND TRADING: STV sees advertising upturn; Angle loss narrows

The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not s ...

June 05 2024
Alliance News

Immupharma PLC Notice of AGM & Annual Report & Accounts

Immupharma PLC 05 June 2024           RNS: RELEASE                                                                                                                                              ...

June 05 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.07-5.511811023621.271.3651.0212052541.21879379DE
4-0.375-23.80952380951.5751.6150.8523928731.19605656DE
12-0.61-33.70165745861.811.9950.8513852821.40620698DE
26-1.04-46.42857142862.242.30.8513166761.56136685DE
52-0.43-26.38036809821.632.90.8317252741.72993705DE
156-6.2-83.78378378387.49.50.8315970183.1647455DE
260-14.74-92.471769134315.9421.30.8313964125.76948887DE

IMM - Frequently Asked Questions (FAQ)

What is the current Immupharma share price?
The current share price of Immupharma is 1.20p
How many Immupharma shares are in issue?
Immupharma has 416,440,000 shares in issue
What is the market cap of Immupharma?
The market capitalisation of Immupharma is GBP 5.33M
What is the 1 year trading range for Immupharma share price?
Immupharma has traded in the range of 0.83p to 2.90p during the past year
What is the PE ratio of Immupharma?
The price to earnings ratio of Immupharma is -1.83
What is the reporting currency for Immupharma?
Immupharma reports financial results in GBP
What is the latest annual profit for Immupharma?
The latest annual profit of Immupharma is GBP -2.92M
What is the registered address of Immupharma?
The registered address for Immupharma is ONE BARTHOLOMEW CLOSE, LONDON, EC1A 7BL
What is the Immupharma website address?
The website address for Immupharma is www.immupharma.com
Which industry sector does Immupharma operate in?
Immupharma operates in the FINANCE DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TIRTiger Royalties And Investments Plc
0.15p
(50.00%)
807k
ASTAscent Resources Plc
2.05p
(24.24%)
3.8M
OPGOpg Power Ventures Plc
6.00p
(16.50%)
357.32k
BEMBeowulf Mining Plc
14.50p
(16.00%)
1,000
MASTMast Energy Developments Plc
0.18p
(12.50%)
5.55M
SNGSynairgen Plc
2.30p
(-38.58%)
844.09k
NMTNeometals Ltd
3.25p
(-23.53%)
9.72k
INDIIndus Gas Limited
7.00p
(-15.66%)
188.82k
PRISPristine Capital Plc
0.375p
(-11.76%)
1M
PDLPetra Diamonds Limited
25.90p
(-10.69%)
318.73k
NTOGNostra Terra Oil And Gas Company Plc
0.0225p
(-2.17%)
41.44M
TRPTower Resources Plc
0.032p
(0.00%)
36.63M
MSMNMosman Oil And Gas Limited
0.0315p
(0.00%)
29.62M
UKOGUk Oil & Gas Plc
0.0215p
(-2.27%)
20.63M
RRRRed Rock Resources Plc
0.0375p
(7.14%)
14.98M

Discussion

View Full Feed
lovethatgreen lovethatgreen 2 minutes ago
You're a pos
RDGL
PC retired PC retired 7 minutes ago
Hi Mr Dorick. Simon D was of the opinion that there had been lawsuits over the original "earth engine" hoax. As you have noted this was a lot more blatant, ie 25Kw from magnets!! The current nonsense hints at off-grid power , rather than stating it in clear language.
FLCX
71chris71 71chris71 18 minutes ago
Usually thieves do not give information! In fact, Mr. Nixon, being the king of thieves, and I would add a scoundrel, has never sent anything! He is only interested in stealing
236T568 236T568 21 minutes ago
Very Sad

David Gergen, Adviser To 4 U.S. Presidents, Has Dementia

https://www.huffpost.com/entry/david-gergen-dementia_n_67647dd6e4b00aa16adf512f
rikkie rikkie 22 minutes ago
Look at Polariton and AMF! They have produced world class products in speed, consumption and size. Look at the patents LWLG has collected in photonics and polymers. Don't tell me this will just disappear. I remain optimistic about the polymer "perkinamine" and have higher expectations now that Yves
LWLG
fuagf fuagf 22 minutes ago
brooklyn13, My take on all of that is unchanged from shortly after i arrived here in 1967. Australia, like every other country, has bigoted people whether the bigotry is based on ethnicity, imagined race or religion. The antipathy against Israel at present is more based on the increasingly geno
Banjo50 Banjo50 33 minutes ago
BIG LOTS FOLDING THE TENT! TOLD YOU SO! COMPLETELY MISMANAGED FOR THE LASR FIVE YEARS!!!
BIGGQ
IVRT IVRT 37 minutes ago
I think the last BMXI carrot is Hall Cadwick. There is no other reason to delay. Cannot replace Hall because the ladder does not go any higher up. The delays have become a millstone around BMXI's neck. Either as you say the audit is fictitious or the audit must be done in January. There are no
BMXI
chereb19 chereb19 52 minutes ago
Isopet has been proven to be profitable
RDGL
QuantumTravesty QuantumTravesty 55 minutes ago
Thanks.
HIRU
knrorrel knrorrel 1 hour ago
very nice
QNCCF
GASMASK GASMASK 1 hour ago
What's/who's TA?
MRGE
JerryCampbell JerryCampbell 2 hours ago
Data entry error the previous day.

Someone mistakenly entered 8,000,000 instead of 800,000. The -7.2m corrects it.
NWBO
georgejjl georgejjl 2 hours ago
I guess that Anavex could have sales of $14 billion during the first full year after approval in 2026 by the EMA in the EU alone based on capturing a 25% market share of the 8 million people in the EU with Alzheimer’s disease at a prescription cost of $7,000 per year per patient.

Go
AVXL
jeunke22 jeunke22 2 hours ago
Thanks KCC , I am still very positive about my investment here. Doing business implies to understand when it is time to adapt to a given set of circumstances. No need to try to go through a wall, if you can go around it. I think that is what has changed here. A more practical and energetic way to g
LWLG
DMC8 DMC8 2 hours ago
Feeling burnout recently fellow shareholders?

Watch the youtube chat on how to manage burnout by Patrice Bonfiglio, President of Sarissa Capital Management LP.
https://youtu.be/wpFutxLn-wk?si=6Rm2JhCbHvgvUcsb
AMRN
lodas lodas 2 hours ago
jhdf51........never buy a Put or a Call option unless you are 100% sure of the outcome at expiration.... why? you only a 50% chance of success... said another way... you either win, or lose...... however by Selling a Put, or Call options, you have a 66% chance of winning, or 2 ways out of three...
COOP
pepeoil pepeoil 2 hours ago
Good morning shrimpers. Bwahaaaaaa. We are broke. Lol
THEDOG 17 THEDOG 17 2 hours ago
O and you may as well clock out because Bio was acquired!! Yeah if you can’t figure it out maybe you should read that report eagle just posted!!!! Acquisition!!!!! Let’s gooo
jhdf51 jhdf51 2 hours ago
My bird in the hand is COOP. Escrow is now a ROC
capable of carrying hopeful escrowers in its talons.

JHD
COOP
jhdf51 jhdf51 2 hours ago
It seems that people playing options are like people going to Vegas.. they never lose.

JHD
COOP
2018trader 2018trader 2 hours ago
Just keep buying the monopoly 7, I mean mag 7
SPY
TCI1 TCI1 2 hours ago
I can’t open the link to the CVS coverage for 2025, would like to see it as they dropped Vascepa in July.

Sleven have you seen any positive or negative changes?
CVS
TCI1 TCI1 2 hours ago
Well UHC has both IPE and Vascepa covered with PA so you would hope and expect all CVD indications to go to Vascepa. Not sure if this is a change or not but by using a PA UHC are exposing themselves to litigation if they prioritise generic for CVD. Of course this is based off insurers adhering to th
AMRN

Your Recent History

LSE
IMM
Immupharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads